Why Is Bruker (BRKR) Up 12.5% Since Last Earnings Report?

It has been about a month since the last earnings report for Bruker (BRKR). Shares have added about 12.5% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Bruker due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for Bruker Corporation before we dive into how investors and analysts have reacted as of late.

Bruker Q2 Earnings Beat, Revenues Miss Estimates

Bruker posted second-quarter 2026 adjusted earnings of 49 cents per share, up 53.1% year over year. The figure beat the Zacks Consensus Estimate of 38 cents by 28.9%.

Quarterly revenues rose 5.2% to $838.5 million but missed the Zacks Consensus Estimate of $853.57 million by 2.2%.

BSI Bookings Signal Better Demand

BSI revenues increased 4.7% year over year to $767.3 million, with organic growth of 2.3%. The segment’s order book rose 10% organically, driven by more than 50% growth in semiconductor orders and more than 20% growth in biopharma bookings.

Segment Mix Favors CALID and BEST

BioSpin revenues edged up 0.2% year over year to $195.7 million. CALID revenues rose 8.6% to $310.3 million, while Nano revenues increased 3.6% to $261.3 million.

BEST revenues climbed 11.9% to $74.2 million, with organic growth of 8.9%, net of intercompany eliminations.

Margins Expand on Cost Actions

Adjusted gross margin expanded 350 basis points year over year to 52.1%. Non-GAAP operating margin widened 510 bps to 14.1%, with adjusted operating income rising 64.6% to $118.5 million.

Bruker delivered about $30 million of cost savings in the quarter and remains on track for more than $140 million of annualized savings in 2026. GAAP results included a $134.9 million non-cash goodwill impairment charge, contributing to a GAAP operating loss of $65.3 million.

Bruker Updates 2026 Outlook

Bruker now expects 2026 revenues of $3.54-$3.57 billion, representing 3%-4% reported growth. Organic growth remains projected at 1%-2%, while the foreign-currency tailwind is now expected at 0.5%, down from 1.5%.

Adjusted earnings guidance remains $2.10-$2.15 per share, implying 15%-17% growth. The company still targets 250-300 bps of adjusted operating margin expansion. For the third quarter, management expects organic revenue to be roughly flat to slightly higher, with about $20 million of semiconductor revenue shifting into the fourth quarter.

How Have Estimates Been Moving Since Then?

It turns out, fresh estimates have trended downward during the past month.

The consensus estimate has shifted -24.1% due to these changes.

VGM Scores

Currently, Bruker has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with an F. Charting a somewhat similar path, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.

Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook

Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Bruker has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research